DAVA Pharmaceuticals Counterpart to Registration Rights Agreement for 7.00% Senior Notes Due 2019

Contract Categories: Business Finance › Registration Rights Agreements
Summary

DAVA Pharmaceuticals, Inc. agrees to be bound as a Guarantor under the Registration Rights Agreement dated May 6, 2014, related to the 7.00% Senior Notes due 2019. This agreement, originally among Endo Finance LLC, Endo Finco Inc., other guarantors, and certain financial institutions, ensures DAVA Pharmaceuticals will comply with the terms and obligations of the Registration Rights Agreement as of August 11, 2014.

Read More Arrow
EX-10.197 3 ex10197-rracounterpartre7n.htm AUG RRA-7.00-2019 Ex. 10.197 - RRA Counterpart re 7% Notes due 2019 (DAVA Guarantee)
Exhibit 10.197

EXECUTION VERSION

Counterpart to Registration Rights Agreement
August 11, 2014
The undersigned hereby absolutely, unconditionally and irrevocably agrees as a Guarantor, as defined in the Registration Rights Agreement, dated May 6, 2014 by and among Endo Finance LLC, a Delaware limited liability company and Endo Finco Inc., a Delaware corporation, the Guarantors party thereto, RBC Capital Markets, LLC and Deutsche Bank Securities Inc., relating to the 7.00% Senior Notes due 2019, to be bound by the terms and provisions of such Registration Rights Agreement.



Exhibit 10.197

IN WITNESS WHEREOF, the undersigned has executed this counterpart as of the date first written above.
DAVA PHARMACEUTICALS, INC.
By:
/s/ Deanna Voss
Name:
Deanna Voss
Title:
Assistant Secretary




[Signature to Registration Rights Agreement Counterpart - 7.00% Senior Notes due 2019]